Readify

Somerset Medical Center’s delayed reporting of abnormal patient incidents

The Good Nurse: A True Story of Medicine, Madness, and Murder

Somerset Medical Center’s delayed reporting of abnormal patient incidents was not simply a lag in paperwork: it left a suspected threat to patients inside the hospital’s own investigative process while outside authorities waited for information. State rules required immediate reporting of events that jeopardized patient health and safety, without requiring hospitals first to establish their cause. Yet the hospital’s administrators said they planned to investigate internally before notifying the state or police. The delay became part of the larger failure to recognize and act on a pattern of unexplained patient harm.

The reporting duty and the first warning

New Jersey regulations required hospitals to report patient-safety events to the New Jersey Department of Health and Senior Services immediately. The cause did not have to be known. That distinction mattered: reporting was meant to alert authorities to a dangerous event, not to wait until an institution had completed its own explanation of it.

At Somerset Medical Center, New Jersey Poison Control pharmacist Bruce Ruck and director Steven Marcus had become alarmed by reports of patients with unusual glucose results. Ruck’s concern reached Marcus, whose judgment was that the evidence was not ambiguous and that patients might be deliberately harmed. He worried that every additional day without acknowledgment could expose more patients to danger. A conversation with Somerset’s administrators was therefore not merely a request for a later case summary; it was an effort to prompt action while the cause remained under investigation.

An internal investigation before external notice

In an email dated July 10, 2003, Marcus recorded what Somerset Medical Center’s risk manager, pharmacy director, chief operating officer, and chief medical officer had told him: the hospital did not plan to report the incidents to the New Jersey Department of Health and Senior Services or the police until after it had conducted a thorough investigation. The proposed order reversed the regulatory priority. Rather than report first and investigate with the responsible authorities informed, the hospital intended to investigate first and decide later what to disclose.

The book’s account places that choice within a broader pattern of hesitation over who should treat the incidents as a possible crime, a patient-safety emergency, or a matter for internal review. The Poison Control Center had urged a response, but Somerset’s administrators retained control over the information and the pace of their inquiry. The gap between a mandatory immediate report and an institution’s preference to finish its own investigation gave the suspected pattern time to remain unresolved outside the hospital.

A delayed fourth incident and escalation

The reporting problem did not end with the initial three unexplained incidents. On September 26, 2003, a senior staff member at the Department of Health and Senior Services reported that Somerset had disclosed a fourth incident that had occurred a month earlier. The hospital had already been warned to report any additional affected patients. The new information therefore revealed not only another abnormal event, but a further delay after an explicit instruction to notify the state.

That disclosure changed the state department’s assessment. Marilyn Dahl, a senior assistant commissioner, wrote that she and other officials saw sufficient reason to suspect foul play. They considered the hospital’s month-long delay in reporting the fourth occurrence irresponsible at best and sought permission to consult the department’s legal office about referring the matter to the Attorney General’s office. The concern was no longer only whether individual clinical events had innocent explanations; it was also whether Somerset had withheld new information after being told to report it.

State-level hesitation and the route to investigators

The escalation itself had been delayed at more than one level. Before Somerset Medical Center administrators contacted the Somerset County Prosecutor’s Office, the Department of Health and Senior Services had already reached out to the New Jersey Attorney General’s office. The book describes the reporting and response chain as having stalled or been sidetracked both within the hospital and at the highest level of the health department.

An earlier state-level response had also been cautious. After the department’s investigator, Edward Harbet, reviewed patient records and Somerset’s internal investigation in July, he could identify no specific finding that explained the relevant laboratory results and said the records would receive further review. Commissioner Cliff Lacey initially considered suspicion of foul play premature and declined a proposed referral to the Attorney General. In September, however, the fourth incident and its month-long reporting delay sharpened the department’s concern. The department contacted the Attorney General’s office that day; Somerset contacted the Somerset County Prosecutor’s Office seven days later.

Consequences for the investigation and the people involved

Delayed disclosure had practical consequences for an investigation already struggling to connect suspicious patient outcomes to drug access and individual actions. When investigators later pursued records from the Pyxis system, they were told that medication-access data remained stored for only thirty days. The relevant records for Reverend Florian Gall, who had died months earlier, were said to be gone. The timing of disclosure did not by itself establish what any missing record would have shown, but it illustrates the investigative cost of relying on information that could expire while the case remained outside police hands.

The uncertainty also reached the nurses. Amy Loughren had objected to a new insulin sign-out procedure because she believed it was inaccurate, and management did not explain what had prompted the change. As rumors spread that insulin, Charles Cullen, and a death were connected, colleagues avoided Amy because she was known as Cullen’s friend; she feared for her job and even wondered whether she herself had made a mistake. When a detective showed her Cullen’s Pyxis record from the night Reverend Florian Gall died, she could no longer dismiss the possibility that her friend had done something terrible. Later, while cooperating with investigators, she felt exposed to dismissal and isolated from the institution where she still worked as a nurse. The reporting delay thus belonged not only to an administrative timeline: it shaped how long staff remained without an explanation, and what risks fell on those who tried to help uncover one.

The episode’s defining conflict is between a duty to disclose danger promptly and an institutional impulse to control the inquiry before outside authorities are involved. The state’s immediate-reporting rule did not require proof of poisoning; it was designed to bring unexplained threats into view. In this case, successive delays left the meaning of the patient incidents contested even as the investigation’s need for timely information grew.